Latest Regulatory Scrutiny News

Page 6 of 24
Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a brief delay as FIRB extends its approval deadline, prompting a reschedule of the critical court hearing to November 23.
Ada Torres
Ada Torres
20 Nov 2025
Bubs Australia Limited reported a solid FY25 with $102.5 million revenue and outlined ambitious FY26 guidance targeting up to $125 million, driven by overseas markets and strategic investments.
Victor Sage
Victor Sage
20 Nov 2025
NexGen Energy has entered the final phase of federal regulatory approval for its flagship Rook I uranium project, marking a pivotal step toward construction and production. This follows over a decade of environmental assessments and provincial approvals.
Maxwell Dee
Maxwell Dee
20 Nov 2025
Infomedia Ltd has announced a fully franked special dividend of 2.9 cents per share, payable in late November, linked to its pending acquisition by McQueen BidCo Pty Ltd.
Sophie Babbage
Sophie Babbage
19 Nov 2025
TPG Telecom has successfully raised $300 million through its institutional reinvestment plan, issuing new shares at a discount to offset recent capital returns and strengthen its balance sheet. The plan faced adjustments due to a tragic incident and volatile market conditions.
Sophie Babbage
Sophie Babbage
19 Nov 2025
Capricorn Metals Ltd has had its CMMO securities class suspended from ASX trading pending regulatory compliance, raising questions about the company’s next steps.
Maxwell Dee
Maxwell Dee
17 Nov 2025
The Takeovers Panel has intervened in the Mayne Pharma and Cosette Pharmaceuticals scheme, issuing interim orders that extend the deal deadline and restrict termination rights to maintain the status quo.
Victor Sage
Victor Sage
14 Nov 2025
The Takeovers Panel has issued interim orders extending the deadline for Mayne Pharma's takeover scheme with Cosette Pharmaceuticals, preventing termination without consent and maintaining the status quo.
Victor Sage
Victor Sage
14 Nov 2025
Solvar Limited reported solid FY25 results with profit growth, a significant dividend hike, and a positive outlook for FY26 driven by loan originations and commercial lending expansion.
Claire Turing
Claire Turing
14 Nov 2025
The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.
Ada Torres
Ada Torres
13 Nov 2025
The ACCC has given informal clearance for the merger between Southern Cross Media Group and Seven West Media, marking a key regulatory milestone. The deal still awaits shareholder and ACMA approvals before completion.
Elise Vega
Elise Vega
13 Nov 2025
Sagalio Energy Limited’s shares have been suspended from ASX trading due to compliance concerns, leaving investors in the dark about the company’s next steps.
Maxwell Dee
Maxwell Dee
12 Nov 2025